Godavari BiorefineriesQ4 FY25

Godavari Biorefineries Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹202.97P/E: 36.0Market Cap: ₹1.0K Cr

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Godavari Biorefineries targets a 3x increase in EBITDA by FY29, driven by growth in ethanol and bio-based specialty chemicals.
  • Ethanol segment growth supported by commissioning of 200-kiloliter/day grain/maize-based distillery in Q4 FY26, adding multi-feedstock capacity.
  • Continued de-bottlenecking and capacity expansions planned for bio-based chemical segment to meet rising demand.
  • Bio-based chemicals EBITDA more than doubled in FY25, indicating strong growth momentum.
  • Strategic diversification into bio-butanol and higher alcohols (licensed technology) expected to boost revenues over next few years.
  • Expansion plans include increased ethanol production from B heavy molasses, sugarcane juice/syrup, and new feedstocks like grain and maize.
  • Long-term growth driven by co-creation with customers focused on green chemicals and energy transition.
  • Expect revenue and margin expansion progress to become evident progressively through FY27-29.

See what Godavari Biorefineries management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no specific mention of any current or planned fundraising through debt or equity in the transcript.
  • The company has strengthened its financial position by reducing debt, which has lowered its interest burden and created headroom for future expansion and strategic investments.
  • Capex plans for FY26 include approximately INR130 crores for the grain-based ethanol facility and investments in debottlenecking bio-based chemicals and biobutanol projects.
  • The company is working on detailed engineering packages for expansion but has not provided firm capital expenditure figures or fundraising requirements yet.
  • Any further clarity on capital expenditure and potential funding needs will be shared in future updates or board meetings.

See what Godavari Biorefineries management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Godavari Biorefineries is investing in a grain/maize-based ethanol facility with a capacity of 200,000 liters per day, expected to be commissioned in Q4 FY26, with an estimated capex of INR 130 crores (net of GST).
  • The company is undertaking debottlenecking initiatives to optimize bio-based specialty chemical production capacity, supporting growth in this segment.
  • Engineering work is underway for a biobutanol project licensed from Catalyxx, which will expand their sustainable chemistry portfolio; detailed engineering design is in progress.
  • Continuous maintenance capex is also planned annually as part of regular operations.
  • Overall capex will support achieving a targeted 3x EBITDA growth by FY29, driven by expansions in both ethanol and specialty chemical segments.

Track Godavari Biorefineries — get its next earnings analysis in your feed

How does Godavari Biorefineries rank vs peers in ?

Pro feature
ThisGodavari Biorefineries
Rev 2Mar 3

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →